Despite the availability of a safe and effective vaccine, measles (rubeola) outbreaks persist. How prepared are you to prevent, recognize, and treat this highly contagious, acute viral respiratory illness?
Low vaccination rates and increasing vaccine hesitancy10,11,12contribute to the persistence of measles as a major cause of childhood morbidity and mortality. National-level MCV1 estimates from the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) 2019 identified only 72 out of 204 ...
51]. According the CDC/Advisory Committee on Immunization Practices (ACIP), vaccine administered on or after age 12 months is 95% effective in preventing measles and is 99% after a second dose [52]. In a literature review of MCV effectiveness studies published during...
Of the 138 patients, 32 (23%) had a documented history of vaccination with measles-containing vaccine (MCV): 25 (18%) patients had received one dose of MCV, and seven (5%) had received two doses of MCV. The remaining 106 (77%) patients reported being unvaccinated. For all persons ...
This case report discusses the challenge of identifying wild‐type measles in an individual who was recently vaccinated with measles‐containing vaccine (MCV). Methods: A positive polymerase chain reaction (PCR) result for measles for an adult who had recently received a measles‐containing vaccine ...
Coverage of one-dose measles-containing vaccine (MCV) increased from 83.8% at baseline to 90.1% after C4D. One-dose MCV coverage was greater than 95% in the Guangxi, Shaanxi, and Gansu provinces. Two-dose MCV coverage increased from 68.5 to 77.6%. House-to-house communication was the most...
Forest plot of multilevel logistic regression, for the determinants of untimely vaccination of the first dose of measles-containing vaccine (MCV1) and the second dose of MCV (MCV2) at household level. OR odds ratio, CI confidence interval Full size image At the village level, the absence of...
Healthcare worker MCV: Measles-containing vaccine MeV: Measles virus MMR: Measles-mumps-rubella ORI: Outbreak response immunization PRNT: Plaque reduction neutralization test TCID: Tissue culture infectious doses WHO: World Health Organization ...
6,7 This finding prompted a withdrawal of a preferential recommendation for use of MMRV as the first measles-containing vaccine (MCV) in the United States and Germany.8,9 Before July 2013, MMRV vaccine was not used in Australia. Two doses of MMR vaccine were scheduled on the National ...
Objective: To obtain an objective index of evaluating the immunization coverage rate of first dose of measles containing vaccine(MCV1)by comparison of the indexes in Guizhou Province.Methods: Multistage random sampling method was applied to draw subjects from healthy children who had no measles histor...